Koninklijke Philips NV vs Rocket Companies Inc. Class A Common Stock — how do they compare? Koninklijke Philips NV trades at $25.17 (market cap $24.60B), while Rocket Companies Inc. Class A Common Stock trades at $10.74 (market cap $29.82B). The key difference: Rocket Companies Inc. Class A Common Stock is the larger of the two by market cap, and Koninklijke Philips NV pays a 4.05% dividend while Rocket Companies Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Koninklijke Philips NV for 84 Days and Rocket Companies Inc. Class A Common Stock for 0 Days on average.
| PHG | RKT | |
|---|---|---|
Market Cap | $24.60B | $29.82B |
Volume | 1,105,836 | 46,995,062 |
Sector | Health | Financials |
52-Week High | $32.91 | $23.44 |
52-Week Low | $23.81 | $10.53 |
Typical Hold Time | 84 Days | 0 Days |
Enterprise Value | $30.96B | $59.81B |
Dividend Yield | 4.05% | — |
Signals from Pluang's Aura AI — not financial advice
PHG trades at $24.89, up 0.61% with a bullish technical signal despite mixed momentum indicators. The company shows strong earnings momentum with three consecutive quarterly beats and a return to profitability in 2025 after previous losses. Recent developments include new product launches in healthcare technology and a $33.7 million ARPA-H award for AI-enabled stroke care. Valuation metrics appear reasonable with P/E of 19.49 and P/S of 1.22.
The outlook remains cautiously optimistic with improving fundamentals but faces execution risks in a competitive healthcare technology market. Analyst consensus leans Hold (63.64%) with no Sell ratings, suggesting stable but not aggressive growth expectations. Key risks include cybersecurity vulnerabilities highlighted by recent hacking incidents and the need to maintain innovation leadership against larger competitors.
Rocket Companies (RKT) trades at $10.83, down 0.37% on the day, with a neutral technical signal and mixed earnings history. The stock is near its 52-week low amid a challenging mortgage market. Recent financials show a net loss of $68 million in 2025 but project a return to profitability in 2026. Analyst consensus is a 'Buy' with a $16.88 price target, though sentiment is tempered by high interest rates and housing market pressures.
Outlook: RKT offers potential upside from current depressed levels if mortgage demand recovers, but faces significant headwinds from persistent high rates and weak housing activity. Risks include competitive pressures and regulatory scrutiny, while opportunities lie in market share gains and cost management improvements. Investors should weigh the cyclical recovery potential against near-term macroeconomic challenges.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →Rocket Companies, Inc. operates a homeownership platform spanning mortgage origination and servicing, real estate, title and closing, and personal finance, with flagship brands including Rocket Mortgage, Rocket Close, Rocket Money, Rocket Loans, and Redfin.
Read more on RKT →